Items where Author is "Li, A."

Article

Li, A. and Alexandru, A. and Chen, Y. and Doi, T. and Dong, S. J. and Draper, T. and Gong, M. and Hasenfratz, A. and Horvath, I. and Lee, F. X. and Liu, K. F. and Mathur, N. and Streuer, T. and Zhang, J. B. (2010) Overlap valence on 2+1 flavor domain wall fermion configurations with deflation and low-mode substitution. PHYSICAL REVIEW D, 82 (11): 114501. ISSN 1550-7998

Conference or Workshop Item

Corbacioglu, S. and Locatelli, F. and Lang, P. and Li, A. and De La Fuente, J. and Wall, D. and Meisel, R. and Shah, A. and Liem, R. and Mapara, M. and Carpenter, B. and Kwiatkowski, J. and Cappellini, M. and Kattamis, A. and Sheth, S. and Grupp, S. and Kohli, P. and Shi, D. and Bobruff, Y. and Ross, L. and Simard, C. and Zhang, L. and Morrow, P. K. and Hobbs, B. and Frangoul, H. (2023) Transfusion independence after exagamglogene autotemcel in patients with transfusion-dependent β-thalassemia. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.

Locatelli, F. and Ailinca-Luchian, S. and Bobruff, Y. and Cappellini, M. Domenica and Corbacioglu, Selim and Domm, J. and Foell, J. and De la Fuente, J. and Handgretinger, R. and Ho, T. W. and Hobbs, W. and Kattamis, A. and Li, A. and Lu, Y. and Palomino, L. and Shanbhag, N. and Sharma, A. and Sheth, S. and Sripakdeevong, P. and Wall, D. and Frangoul, H. (2021) CTX001 FOR TRANSFUSION-DEPENDENT -THALASSEMIA (TDT): SAFETY AND EFFICACY RESULTS FROM THE ONGOING CLIMB THAL-111 STUDY OF AUTOLOGOUS CRISPR-CAS9-MODIFIED CD34+HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS). In: 48th Congress of the Italian Society of Hematology, 24 - 27 October 2021, Milano, Italy.

Corbacioglu, Selim and Locatelli, F. and Ailinca-Luchian, S. and Bobruff, Y. and Cappellini, M. D. and Domm, J. and Foell, J. and de la Fuente, J. and Handgretinger, R. and Ho, T. W. and Hobbs, W. and Kattamis, A. and Li, A. and Lu, Y. and Palomino, L. and Shanbhag, N. and Sharma, A. and Sheth, S. and Sripakdeevong, P. and Wall, D. and Frangoul, H. (2021) CTX001 for transfusion-dependent beta-thalassemia (TDT): safety and efficacy results from the ongoing CLIMB THAL-111 study of autologous CRISPR-CAS9-modified CD34(+) hematopoietic stem and progenitor cells (HSPCs). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Somford, D. M. and Daneshmand, S. and Grivas, P. and Sridhar, S. and Gupta, S. and Bellmunt, J. and Sonpavde, G. and Fleming, M. T. and Lerner, S. P. and Loriot, Y. and Li, A. and Takkele, H. and Andresen, C. and Rearden, J. and Shepherd, S. Peacock and Schnabel, M. J. and Pal, S. K. (2020) PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 alterations. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.